FDA |
Food and Drug Administration |
FGF1 |
Fibroblast growth factor 1 |
FGF2 |
fibroblast growth factor 2 |
FGFR1 |
Fibroblast growth factor receptor 1 |
GAPDH |
Glyceraldehyde 3-phosphate dehydrogenase |
IgG |
Immunoglobulin G: IHC: Immuno HistoChemistry |
LATS1 |
Large tumor suppressor kinase 1 |
MDA Pca |
MD Anderson Prostate Cancer |
MET |
Mesenchymal to Epithelial Transition |
MST1/2 |
Mammalian Ste20-like kinases 1/2 |
NOD/SCID |
non-obese diabetic/severe combined immune deficiency |
PBS |
phosphate buffered saline |
PCR |
Polymerase chain reaction |
qRT-PCR |
Quantitative Real-Time Polymerase Chain Reaction |
RPMO |
Roswell Park Memorial Institute |
sh-c-Met |
Short hairpin-C-MET |
TKI |
Tyrosine kinase inhibitors |
TBX5 |
T-Box Transcription Factor 5 |
VEGFR2 |
Vascular endothelial growth factor receptor 2 |
YAP |
Yes-associated protein 1 |